Evidence map›Paper›PMID 27736642›Full record

ArticleCell host & microbe2016

Zika and Other Emerging Viruses: Aiming at the Right Target.

Kai Dallmeier, Johan Neyts

Abstract readComment
In one paragraph

Article in Cell host & microbe, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Pathomechanisms, therapeutic targets and potent inhibitors of some beta-coronaviruses from bench-to-bedside.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2021
    Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Kai DallmeierRega Institute for Medical Research, Department of Microbiology & Immunology, University of Leuven (KU Leuven), 3000 Leuven, Belgium.
Johan NeytsRega Institute for Medical Research, Department of Microbiology & Immunology, University of Leuven (KU Leuven), 3000 Leuven, Belgium. Electronic address: johan.neyts@kuleuven.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Zika emergency calls for urgent countermeasures. Recently, Barrows et al. (2016) and Xu et al. (2016) conducted in vitro anti-ZIKV screens to identify potential therapeutics. The off-label use of drugs that may protect against Zika virus-induced brain damage has, however, to be balanced with their risk during pregnancy.

Indexed as

Off-Label UseBrain InjuriesFemaleHumansPregnancyPregnancy Complications, InfectiousRiskZika Virus Infection

Identifiers

PMID27736642
PMCPMC7172229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.